Cases 41 - 50 of 573
Gibson v. Boehringer Ingelheim Corporation et al
as 3:2023cv20171
Plaintiff:
Tommy Gibson
Defendant:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals, Inc and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Burris v. Boehringer Ingelheim Corporation et al
as 3:2023cv20146
Plaintiff:
William Burris
Defendant:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Bennett v. Boehringer Ingelheim Corporation et al
as 3:2023cv20097
Plaintiff:
Deborah Bennett
Defendant:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DAWSON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv01159
Plaintiff:
DIANA DAWSON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN, N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
In Re: Valsartan Losartan and Irbesartan Products
as 23-8007
Petitioner:
AUROBINDO PHARMA LTD, AUROBINDO PHARMA USA INC, AUROLIFE PHARMA LLC and others
Respondent:
CONSUMER ECONOMIC LOSS PLAINTIFFS, THIRD-PARTY PAYOR PLAINTIFFS and MEDICAL MONITORING PLAINTIFFS
HALE et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv00575
Plaintiff:
WILEY HALE and STARRTRYNEA REEVES
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MATRACHISIA v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv00341
Plaintiff:
JOHN MATRACHISIA
Defendant:
AUROBINDO PHARMA, LTD., AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MORGAN v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv00166
Plaintiff:
PHILLIP MORGAN
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD., ACTAVIS, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MAGO v. MYLAN LABORATORIES LTD. et al
as 1:2022cv07601
Plaintiff:
JHEINGEL MAGO
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
COBERLY v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv07450
Plaintiff:
David Coberly
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
